Healthy hearing available to all
Akouos is a precision genetic medicine company developing gene therapies to restore, improve, and preserve high-acuity physiologic hearing for people with disabling hearing loss. Focused on inner ear delivery and AAV gene therapy platforms, it was acquired by Eli Lilly. Targets genetic forms of hearing loss affecting 466 million worldwide.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountOct 2022
Jan 2021
Mar 2020
Aug 2018
Oct 2017
Create a free account to see which investors have funded this company.
Create Free AccountBiopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...
Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
